Statistics for Seguridad del dupilumab, mepolizumab y omalizumab como tratamiento en pacientes con rinosinusitis crónica con poliposis nasal
Total visits
| views | |
|---|---|
| Seguridad del dupilumab, mepolizumab y omalizumab como tratamiento en pacientes con rinosinusitis crónica con poliposis nasal | 17 |
Total visits per month
| views | |
|---|---|
| November 2025 | 0 |
| December 2025 | 4 |
| January 2026 | 6 |
| February 2026 | 2 |
| March 2026 | 2 |
| April 2026 | 3 |
| May 2026 | 0 |
File Visits
| views | |
|---|---|
| 1543_Burgos.pdf | 132 |
Visitas de archivo por mes
| views | |
|---|---|
| November 2025 | 0 |
| December 2025 | 14 |
| January 2026 | 31 |
| February 2026 | 27 |
| March 2026 | 19 |
| April 2026 | 41 |
| May 2026 | 0 |